These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17417657)

  • 1. Severe intravascular haemolysis following minor group mismatched peripheral blood stem cell transplantation.
    Nair V; Sharma A; Ratheesh J; Das S; Mishra DK; Kale R; Grover N; Mohan C
    Bone Marrow Transplant; 2007 Jun; 39(12):805-6. PubMed ID: 17417657
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
    Yazer MH; Triulzi DJ
    Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.
    Deotare UR; Vishwabandya A; Mathews V; George B; Srivastava A; Chandy M
    Bone Marrow Transplant; 2006 Jun; 37(12):1149-50. PubMed ID: 16699532
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.
    Curtin NJ; Schwarer AP
    Clin Lab Haematol; 2005 Jun; 27(3):206-8. PubMed ID: 15938729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom burden in patients undergoing autologous stem-cell transplantation.
    Anderson KO; Giralt SA; Mendoza TR; Brown JO; Neumann JL; Mobley GM; Wang XS; Cleeland CS
    Bone Marrow Transplant; 2007 Jun; 39(12):759-66. PubMed ID: 17438588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation.
    Remberger M; Watz E; Ringdén O; Mattsson J; Shanwell A; Wikman A
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):675-82. PubMed ID: 17531777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella pertussis respiratory infection following hematopoietic stem cell transplantation: time for universal vaccination?
    Florax A; Ehlert K; Becker K; Vormoor J; Groll AH
    Bone Marrow Transplant; 2006 Nov; 38(9):639-40. PubMed ID: 16964268
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
    Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
    Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
    Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
    Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
    Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A prospective and randomized study of two conditioning regimens in treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation].
    Zhang W; Zhou DB; Zhao Y; Leng XM; Zhang JP; Jiang Y; Jiao L; Wang SJ; Duan MH; Tang FL; Shen T
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1689-92. PubMed ID: 17825150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
    Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
    Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
    Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
    Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia].
    Tong XZ; Xu DR; Zou WY; Li J; Luo SK; Peng AH; Zhang GC; Zheng D
    Ai Zheng; 2007 Aug; 26(8):914-8. PubMed ID: 17697559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients.
    De Matteis S; Piccirillo N; Laurenti L; Chiusolo P; Sorà F; d'Onofrio G; Leone G; Sica S
    Transfusion; 2008 Dec; 48(12):2645-6; author reply 2646-7. PubMed ID: 19055530
    [No Abstract]   [Full Text] [Related]  

  • 17. Autologous stem cell transplantation in lymphoma.
    Schmitz N; Buske C; Gisselbrecht C
    Semin Hematol; 2007 Oct; 44(4):234-45. PubMed ID: 17961722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation.
    Widmann T; Kneer H; König J; Herrmann M; Pfreundschuh M
    Exp Hematol; 2008 Jan; 36(1):104-10. PubMed ID: 17949890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The haploidentical option for high-risk haematological malignancies.
    Aversa F; Reisner Y; Martelli MF
    Blood Cells Mol Dis; 2008; 40(1):8-12. PubMed ID: 17905610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A.
    Harris SB; Josephson CD; Kost CB; Hillyer CD
    Transfusion; 2007 Aug; 47(8):1412-7. PubMed ID: 17655585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.